SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000320017-24-000013
Filing Date
2024-04-17
Accepted
2024-04-17 16:04:04
Documents
13
Period of Report
2024-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K clbs-20240415.htm   iXBRL 8-K 24234
  Complete submission text file 0000320017-24-000013.txt   151818

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clbs-20240415.xsd EX-101.SCH 1895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clbs-20240415_lab.xml EX-101.LAB 22804
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clbs-20240415_pre.xml EX-101.PRE 13042
16 EXTRACTED XBRL INSTANCE DOCUMENT clbs-20240415_htm.xml XML 2825
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 24850969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)